Darren Weissman

Medicine · Health Sciences

7h-index789citations18works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Tuberculosis Research and Epidemiology(7), Gastrointestinal motility and disorders(6), Pneumocystis jirovecii pneumonia detection and treatment(5), Gastroesophageal reflux and treatments(4), Mycobacterium research and diagnosis(3)

Publications17 total

Sa2099: LONG-TERM SAFETY OF LINACLOTIDE IN TREATING PEDIATRIC PATIENTS AGED 7–17 YEARS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C): INTERIM RESULTS FROM A PHASE 3 STUDY
Gastroenterology·2025
Mo2015 SAFETY OF LINACLOTIDE IN PEDIATRIC PATIENTS WITH FUNCTIONAL CONSTIPATION: A POOLED ANALYSIS OF PLACEBO-CONTROLLED RANDOMIZED-CONTROLLED TRIALS
Gastroenterology·2023· 1 cited
Single‐dose Pharmacokinetics of Eluxadoline in Healthy Participants With Normal Renal Function and Participants With Renal Impairment
Clinical Pharmacology in Drug Development·2022· 1 citedOpen Access
An Open‐Label Study to Evaluate the Effect of Eluxadoline on the Single‐Dose Pharmacokinetics of Midazolam in Healthy Participants
Clinical Pharmacology in Drug Development·2022· 3 citedOpen Access
Linaclotide utilization and potential for off-label use and misuse in three European countries
Therapeutic Advances in Gastroenterology·2022· 4 citedOpen Access
Post-marketing reports of pancreatitis in eluxadoline-treated patients pre and post US label change
Therapeutic Advances in Gastroenterology·2021· 4 citedOpen Access
Safety and tolerability of linaclotide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: pooled Phase 3 analysis
Expert Review of Gastroenterology & Hepatology·2019· 17 citedOpen Access
Safety and Tolerability of Linaclotide for the Treatment of CIC and IBS-C: A Pooled Analysis of Phase 3-3b Placebo-Controlled Trials in North America: 2017 Presidential Poster Award
The American Journal of Gastroenterology·2017
Minimal Diversity of Drug-Resistant<i>Mycobacterium tuberculosis</i>Strains, South Africa1
Emerging infectious diseases·2014· 41 citedOpen Access
Minimal Diversity of Drug-Resistant Mycobacterium tuberculosis Strains,
2014· 1 cited
Nosocomial Transmission of Extensively Drug-Resistant Tuberculosis in a Rural Hospital in South Africa
The Journal of Infectious Diseases·2012· 140 citedOpen Access
Abstract 3884: Stroke Subtypes in Hispanic Patients in the NINDS Stroke Genetics Network (SiGN): A Comparison of Two Classification Systems
Stroke·2012· 1 cited
Abstract 11: The Utility of Causative Classification System: Correlation between Causative and Phenotypic Stroke Subtypes
Stroke·2012
Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting
The International Journal of Tuberculosis and Lung Disease·2011· 102 citedOpen Access
Social Network And Molecular Analysis To Evaluate Hospital Transmission Of Extensively Drug-Resistant Tuberculosis (XDR TB) In South Africa
2011
Predictors of Multidrug- and Extensively Drug-Resistant Tuberculosis in a High HIV Prevalence Community
PLoS ONE·2010· 97 citedOpen Access
HIV Coinfection in Multidrug- and Extensively Drug-Resistant Tuberculosis Results in High Early Mortality
American Journal of Respiratory and Critical Care Medicine·2009· 313 cited

Frequent Co-authors

Neel R. Gandhi(7), Anthony P. Moll(7), Gerald Friedland(5), Neha Shah(4), Prashini Moodley(4), A. Willem Sturm(4), Jason R. Andrews(3), Moonseong Heo(3), Gerald Friedland(2), Barry N. Kreiswirth(2), Barun Mathema(2), James C.M. Brust(2), N. Sarita Shah(2), Yuming Ning(2), Judy Nee(2), Jeffrey M. Johnston(2), Elizabeth P. Shea(2), Kenneth Tripp(2), Steven J. Shiff(2), Susan M. Fox(2)